These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22965767)

  • 21. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
    Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.
    Bell R; Lipham J; Louie B; Williams V; Luketich J; Hill M; Richards W; Dunst C; Lister D; McDowell-Jacobs L; Reardon P; Woods K; Gould J; Buckley FP; Kothari S; Khaitan L; Smith CD; Park A; Smith C; Jacobsen G; Abbas G; Katz P
    Gastrointest Endosc; 2019 Jan; 89(1):14-22.e1. PubMed ID: 30031018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation analysis between Dx-pH monitoring and proton pump inhibitor test in the diagnosis of laryngopharyngeal reflux disease].
    Chen ZL; Wu HW; Mei XW; Yin WH; Xu SY; Liu SQ; Chen YC; Wang G; Zhang CJ; Ding XL; Wu JN
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 55(1):34-39. PubMed ID: 31954386
    [No Abstract]   [Full Text] [Related]  

  • 25. Persistent Postprandial Regurgitation vs Rumination in Patients With Refractory Gastroesophageal Reflux Disease Symptoms: Identification of a Distinct Rumination Pattern Using Ambulatory Impedance-pH Monitoring.
    Nakagawa K; Sawada A; Hoshikawa Y; Nikaki K; Sonmez S; Woodland P; Yazaki E; Sifrim D
    Am J Gastroenterol; 2019 Aug; 114(8):1248-1255. PubMed ID: 31246694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Pepsin and Oropharyngeal pH-Monitoring to Assess the Postoperative Outcome of Patients with Laryngopharyngeal Reflux: Results of a Pilot Trial.
    Weitzendorfer M; Pfandner R; Antoniou SA; Langsteger W; Witzel K; Emmanuel K; Koch OO
    J Laparoendosc Adv Surg Tech A; 2017 Sep; 27(9):937-943. PubMed ID: 28731842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined pH-impedance monitoring and high-resolution manometry of Japanese patients treated with proton-pump inhibitors for persistent symptoms of non-erosive reflux disease.
    Yamashita H; Ashida K; Fukuchi T; Nagatani Y; Koga H; Senda K; Eguchi T; Ubukata S; Kawaguchi S; Ueda A; Tanaka T; Ohashi R; Ito D
    J Smooth Muscle Res; 2012; 48(5-6):125-35. PubMed ID: 23538509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acid reflux detection and symptom-reflux association using 4-day wireless pH recording combining 48-hour periods off and on PPI therapy.
    Garrean CP; Zhang Q; Gonsalves N; Hirano I
    Am J Gastroenterol; 2008 Jul; 103(7):1631-7. PubMed ID: 18557714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual pH Probes Without Proximal Esophageal and Pharyngeal Impedance May Be Deficient in Diagnosing LPR.
    Borges LF; Chan WW; Carroll TL
    J Voice; 2019 Sep; 33(5):697-703. PubMed ID: 30082108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nissen Fundoplication for Laryngopharyngeal Reflux After Patient Selection Using Dual pH, Full Column Impedance Testing: A Pilot Study.
    Carroll TL; Nahikian K; Asban A; Wiener D
    Ann Otol Rhinol Laryngol; 2016 Sep; 125(9):722-8. PubMed ID: 27217426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual pH with Multichannel Intraluminal Impedance Testing in the Evaluation of Subjective Laryngopharyngeal Reflux Symptoms.
    Cumpston EC; Blumin JH; Bock JM
    Otolaryngol Head Neck Surg; 2016 Dec; 155(6):1014-1020. PubMed ID: 27554506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: The laryngological manifestations of reflux disease; why the scepticism?
    Mahieu HF
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():17-24. PubMed ID: 18081645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of the efficacy of proton-pump inhibitors in patients with contact granuloma using 24-hour combined dual channel pH/impedance monitoring.
    Kim BH; Park H; Shin CM; Huh G; Jung YH; Jeong WJ
    Auris Nasus Larynx; 2024 Jun; 51(3):548-552. PubMed ID: 38537558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease.
    Malhotra A; Freston JW; Aziz K
    J Clin Gastroenterol; 2008 Mar; 42(3):271-8. PubMed ID: 18223497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study with pharyngeal and esophageal 24-hour pH-impedance monitoring in patients with laryngopharyngeal symptoms refractory to proton pump inhibitors.
    Dulery C; Lechot A; Roman S; Bastier PL; Stoll D; de Gabory L; Zerbib F
    Neurogastroenterol Motil; 2017 Jan; 29(1):. PubMed ID: 27424517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oropharyngeal pH monitoring for laryngopharyngeal reflux: is it a reliable test before therapy?
    Vailati C; Mazzoleni G; Bondi S; Bussi M; Testoni PA; Passaretti S
    J Voice; 2013 Jan; 27(1):84-9. PubMed ID: 23159026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responders to proton pump inhibitors.
    Ribolsi M; Emerenziani S; Petitti T; Addarii MC; Balestrieri P; Cicala M
    Dig Liver Dis; 2012 Jul; 44(7):549-54. PubMed ID: 22366345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.